NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

I have no quarrel with what you wrote. But just imagine if there was no aspirin and it just got invented today, This is a treatment that reduces high fever (among other things). If they now ran trials to put aspirin on the market as a treatment for high fever, would they have to run a separate trial for each indication wherein fever occurs - a very large number of possible causes of fever? Or simply run one large trial looking at fever as a single problem they wish to treat and disregards the differences that may exist for the purposes of this trial. I understand this a very imperfect analogy, but I think it crudely makes the point I wish to make - and not differentiate between a fever in a flu patient versus a fever in say a covid patient or any of the other multitude of causes of fever.